Country websites:

Investors

Expert Call: Innovation in the Renal Care Continuum

September 20, 2021

The time has changed to 4:00 - 5:00 pm CEST (virtual event, with Q&A session)

with Dr. Olaf Schermeier, Chief Executive Officer for Global Research and Development

Learn more
Press release

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is investing an additional USD 25 million in the U.S. medical company Humacyte, Inc.

Short News

Fresenius Medical Care North America opens a new laboratory in Mississippi, USA. With 200,000-square-foot (19,000 square-meters), it is the company’s largest facility of this kind.

  • You are interested in our news?
  • You are interested in our publications?

newsletter registration

Order form

Here you may order printed copies of our magazines, profiles and SEC filings.

In order to protect the environment and better meet the changing user behavior of our target groups, the annual report as well as our quarterly financial reports are published as digital publications only.

Our strategy: The Renal Care Continuum

Creating the future of health care for chronically and critically ill patients across the Renal Care Continuum by leveraging our core competencies.

Offering sustainable solutions with innovative products and services of the highest quality at reliable costs.

Learn more

OUR VISION BECOMES REALITY

Our Annual Report, Corporate Magazine and Company Profile 2020.

Visit also our Facts & Figures 2020 page.

Learn more
Reporting

Report on 3rd quarter 2021: Earnings Release and Conference Call

Reporting

Quarterly financial report within the 2nd half-year (Q3)

Virtual Conference

Berenberg and Goldman Sachs 10th German Corporate Conference

Virtual Conference

Bernstein’s 18th Pan European Annual Strategic Decisions Conference